These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6934556)

  • 21. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of d-amphetamine on behavioral and autonomic thermoregulation in mice.
    Bushnell PJ; Gordon CJ
    Pharmacol Biochem Behav; 1987 Jul; 27(3):431-5. PubMed ID: 3659066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphetamine increases activity but not exploration in humans and mice.
    Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W
    Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.
    Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
    Neuroscience; 1998 Oct; 86(3):959-65. PubMed ID: 9692731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of scopolamine and D-amphetamine on one-way, shuttle and inhibitory avoidance: a diallel analysis in mice.
    Anisman H
    Pharmacol Biochem Behav; 1975; 3(6):1037-42. PubMed ID: 1223892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
    McNamara RK; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan JR; Stanford K; Richtand NM
    Neuroscience; 2006 Nov; 143(1):141-53. PubMed ID: 16938406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Segal DS
    Science; 1975 Oct; 190(4213):475-7. PubMed ID: 1166317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in mice.
    Bushnell PJ
    Pharmacol Biochem Behav; 1986 Jul; 25(1):161-70. PubMed ID: 3018791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat production and heat loss in d-amphetamine hyperthermia in aggregated Swiss Webster and BDF mice.
    Craigmill AL; Kupferberg HJ; Miller JW
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):362-9. PubMed ID: 4767574
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse.
    Hussey JS; Vincent ND; Davies JA
    Psychopharmacology (Berl); 1983; 81(4):327-31. PubMed ID: 6228947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain differences in amphetamine sensitivity in mice. I. A diallel analysis of open field activity.
    Kitahama K; Valatx JL
    Psychopharmacology (Berl); 1979 Nov; 66(2):189-94. PubMed ID: 119262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No tolerance to antiaggressive effect of d-amphetamine in mice.
    O'Donnell JM; Miczek KA
    Psychopharmacology (Berl); 1980; 68(2):191-6. PubMed ID: 6776565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice.
    Zocchi A; Orsini C; Cabib S; Puglisi-Allegra S
    Neuroscience; 1998 Jan; 82(2):521-8. PubMed ID: 9466458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in drug-induced rotation in two strains of rats.
    Brass CA; Glick SD
    Brain Res; 1981 Oct; 223(1):229-34. PubMed ID: 7284807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of lead, d-amphetamine, and time of day on activity levels in the mouse.
    Dolinsky Z; Fink E; Burright RG; Donovick PJ
    Pharmacol Biochem Behav; 1981 Jun; 14(6):877-80. PubMed ID: 7255522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129X1/SvJ, C3H/HeJ, and CD-1 mice.
    McKerchar TL; Zarcone TJ; Fowler SC
    J Neurosci Methods; 2006 May; 153(1):48-54. PubMed ID: 16290200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity.
    White BC; Keller GE
    Pharmacol Biochem Behav; 1984 Mar; 20(3):383-6. PubMed ID: 6709673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.